Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Schizophrenia

Free Subscription 09.12.2024 1 Am J Med Genet B Neuropsychiatr Genet 2 Biol Psychiatry 3 Br J Psychiatry 1 Brain Res 2 Can J Psychiatry 1 J Clin Psychiatry 1 J Clin Psychopharmacol 1 J Psychiatry Neurosci 2 Mol Psychiatry 1 PLoS Med 6 Psychiatry Res 6 Psychol Med 5 Schizophr Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Med Genet B Neuropsychiatr Genet

1. TANG H, Chen S, Yi L, Xu S, et al
   Circadian Rhythms Correlated in DNA Methylation and Gene Expression Identified in Human Blood and Implicated in Psychiatric Disorders.
   Am J Med Genet B Neuropsychiatr Genet. 2025;198:e33005.
   PubMed         Abstract available
   
   

   
   Biol Psychiatry

2. SANTONI M, Pistis M
   Maternal Immune Activation and Endocannabinoid System: Focus on Two-Hit Models of Schizophrenia.
   Biol Psychiatry. 2024 Nov 29:S0006-3223(24)01783.
   PubMed         Abstract available
   
   
3. ALAMIA A, Gordillo D, Chkonia E, Roinishvili M, et al
   Oscillatory traveling waves provide evidence for predictive coding abnormalities in schizophrenia.
   Biol Psychiatry. 2024 Nov 28:S0006-3223(24)01782.
   PubMed         Abstract available
   
   

   
   Br J Psychiatry

4. NAUGHTON S, McGinty G, Duffy N, Marshall D, et al
   Intervening early across the lifespan: going beyond youth-focused psychosis care to meet the needs of women.
   Br J Psychiatry. 2024 Dec 4:1-3. doi: 10.1192/bjp.2024.
   PubMed         Abstract available
   
   
5. YANG LH, Grivel MM, Blasco D, Girgis RR, et al
   Parsing stigma's relationship with the psychosocial functioning of youth identified as at clinical high risk for psychosis: evaluating whether symptom stigma or labelling stigma is stronger.
   Br J Psychiatry. 2024 Dec 4:1-9. doi: 10.1192/bjp.2024.
   PubMed         Abstract available
   
   
6. CHESNEY E, Reilly TJ, Scott F, Slimani I, et al
   Psychosis associated with cannabis withdrawal: systematic review and case series.
   Br J Psychiatry. 2024 Dec 3:1-12. doi: 10.1192/bjp.2024.
   PubMed         Abstract available
   
   

   
   Brain Res

7. CIZUS E, Jasinskyte U, Guzulaitis R
   Effects of acute and chronic ketamine administration on spontaneous and evoked brain activity.
   Brain Res. 2025;1846:149232.
   PubMed         Abstract available
   
   

   
   Can J Psychiatry

8. VAN L, Heung T, Reyes NGD, Boot E, et al
   Real-World Treatment of Schizophrenia in Adults With a 22q11.2 Microdeletion: Traitement dans le monde reel de la schizophrenie chez des adultes atteints du syndrome de microdeletion 22q11.2.
   Can J Psychiatry. 2024 Dec 6:7067437241293983. doi: 10.1177/07067437241293983.
   PubMed         Abstract available
   
   
9. WEIDENAUER A, Garani R, Campos Oller P, Belen Blasco M, et al
   Impact of Stress on the Endocannabinoid System: A [(11)C]-CURB Positron Emission Tomography Study in Early Psychosis: Les effets du stress sur le systeme endocannabinoide : etude par tomographie par emission de positons avec l'indicateur radioactif [1
   Can J Psychiatry. 2024 Dec 4:7067437241300958. doi: 10.1177/07067437241300958.
   PubMed         Abstract available
   
   

   
   J Clin Psychiatry

10. BALLON JS, Kahn RS, Arevalo C, Dunbar M, et al
    Long-Term Safety, Tolerability, and Durability of Treatment Effect of Olanzapine and Samidorphan: Results of a 4-Year Open-Label Study.
    J Clin Psychiatry. 2024;86:24m15511.
    PubMed         Abstract available
    
    

    
    J Clin Psychopharmacol

11. TAKEUCHI H, Uchida H
    Efficacy and Safety of Dose Increase From 40 mg/d to 80 mg/d of Lurasidone in Patients With Schizophrenia: A Post Hoc Analysis of Extension Trial.
    J Clin Psychopharmacol. 2024 Dec 2. doi: 10.1097/JCP.0000000000001943.
    PubMed         Abstract available
    
    

    
    J Psychiatry Neurosci

12. WANG P, Jiang L, Hu J, Jiang Z, et al
    The amino acid metabolism pathway of peripheral T lymphocytes and ketamine-induced schizophrenia-like phenotype.
    J Psychiatry Neurosci. 2024;49:E413-E426.
    PubMed         Abstract available
    
    

    
    Mol Psychiatry

13. BERNSTEIN HG, Nussbaumer M, Vasilevska V, Dobrowolny H, et al
    Glial cell deficits are a key feature of schizophrenia: implications for neuronal circuit maintenance and histological differentiation from classical neurodegeneration.
    Mol Psychiatry. 2024 Dec 5. doi: 10.1038/s41380-024-02861.
    PubMed         Abstract available
    
    
14. SCHALBROECK R, van Hooijdonk CFM, Bos DPA, Booij J, et al
    Chronic social stressors and striatal dopamine functioning in humans: A systematic review of SPECT and PET studies.
    Mol Psychiatry. 2024;29:3841-3856.
    PubMed         Abstract available
    
    

    
    PLoS Med

15. HU Y, Gao L, Zhou L, Liu W, et al
    Rare but elevated incidence of hematological malignancy after clozapine use in schizophrenia: A population cohort study.
    PLoS Med. 2024;21:e1004457.
    PubMed         Abstract available
    
    

    
    Psychiatry Res

16. KUMAR M, Choudhary H, Chawla N
    Association of antipsychotic formulations with sudden cardiac death in patients with schizophrenia: A nationwide population-based case-control study: Letter to the editor.
    Psychiatry Res. 2024;343:116299.
    PubMed        
    
    
17. PISANU C, Congiu D, Meloni A, Paribello P, et al
    Sex differences in shared genetic determinants between severe mental disorders and metabolic traits.
    Psychiatry Res. 2024;342:116195.
    PubMed         Abstract available
    
    
18. FLORENTIN S, Neumark Y, Roe D, Rosca P, et al
    The relationship between community-based psychiatric rehabilitation pathways and re-hospitalization trajectories: A three-decade follow-up.
    Psychiatry Res. 2024;342:116216.
    PubMed         Abstract available
    
    
19. SOLDEVILA-MATIAS P, Sanchez-Orti JV, Correa-Ghisays P, Balanza-Martinez V, et al
    Exercise as a promoter of neurocognitive improvement in people with psychiatric disorders and comorbid obesity: A randomized controlled trial.
    Psychiatry Res. 2024;342:116226.
    PubMed         Abstract available
    
    
20. WYSOKINSKI A, Dreczka J
    Clozapine Toxicity Predictor: Deep neural network model predicting clozapine toxicity and its therapeutic dose range.
    Psychiatry Res. 2024;342:116256.
    PubMed         Abstract available
    
    
21. GONCALVES CC, Waters Z, Quirk SE, Haddad PM, et al
    Barriers and facilitators to mental health care access and engagement for LGBTQA+ people with psychosis: A scoping review.
    Psychiatry Res. 2024;343:116281.
    PubMed         Abstract available
    
    

    
    Psychol Med

22. AUSTIN-ZIMMERMAN I, Spinazzola E, Quattrone D, Wu-Choi B, et al
    The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies.
    Psychol Med. 2024 Dec 6:1-13. doi: 10.1017/S0033291724002058.
    PubMed         Abstract available
    
    
23. YEH D, He Q, Krebs E, Iftimovici A, et al
    Cognitive impairment in the schizophrenia spectrum: exploring the relationships of the g-factor with sociodemography, psychopathology, neurodevelopment, and genetics.
    Psychol Med. 2024 Dec 2:1-12. doi: 10.1017/S0033291724002538.
    PubMed         Abstract available
    
    
24. YANG KC, Yang BH, Lan CC, Liu MN, et al
    Striatal and peripheral dopaminergic alterations related to cognitive impairment in patients with schizophrenia.
    Psychol Med. 2024 Dec 2:1-11. doi: 10.1017/S0033291724002228.
    PubMed         Abstract available
    
    
25. SKLAR AL, Matinrazm S, Esseku A, Lopez-Caballero F, et al
    Longitudinal evaluation of the early auditory gamma-band response and its modulation by attention in first-episode psychosis.
    Psychol Med. 2024 Dec 2:1-9. doi: 10.1017/S0033291724003052.
    PubMed         Abstract available
    
    
26. CAMPBELL-SILLS L, Papini S, Norman SB, Choi KW, et al
    Associations of polygenic risk scores with posttraumatic stress symptom trajectories following combat deployment.
    Psychol Med. 2023;53:6733-6742.
    PubMed         Abstract available
    
    
27. HAN S, Xue K, Chen Y, Xu Y, et al
    Identification of shared and distinct patterns of brain network abnormality across mental disorders through individualized structural covariance network analysis.
    Psychol Med. 2023;53:6780-6791.
    PubMed         Abstract available
    
    

    
    Schizophr Res

28. ZHU Z, Roy D, Feng S, Vogler B, et al
    AI-based medication adherence prediction in patients with schizophrenia and attenuated psychotic disorders.
    Schizophr Res. 2024;275:42-51.
    PubMed         Abstract available
    
    
29. ODUOLA S, D'Andrea G, Smimmo D, Menchetti M, et al
    Pathways to care: Source of referral at first-episode psychosis, a cross-country comparison between Bologna and South London.
    Schizophr Res. 2024;275:35-41.
    PubMed         Abstract available
    
    
30. SAGER REH, North HF, Weissleder C, Clearwater MS, et al
    Divergent changes in complement pathway gene expression in schizophrenia and bipolar disorder: Links to inflammation and neurogenesis in the subependymal zone.
    Schizophr Res. 2024;275:25-34.
    PubMed         Abstract available
    
    
31. DAZZI F, Shafer A
    Meta-analysis of the factor structure of the Scale for the Assessment of Negative Symptoms (SANS) and the Scale for the Assessment of Positive Symptoms (SAPS).
    Schizophr Res. 2024;274:464-472.
    PubMed         Abstract available
    
    
32. BABADI B, Dokholyan K, DeTore NR, Tootell RBH, et al
    Arousal responses to personal space intrusions in psychotic illness: A virtual reality study.
    Schizophr Res. 2024;274:158-170.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.